New-generation of fluorescently-labeled charge-neutralized oligonucleotides as probes for the detection and quantification of micrornas and oligonucleotide-based therapeutics in biological samples
Ended Project Grant Awarded Last action
- Award ID
- R43GM130187
- Recipient
-
Zata Pharmaceuticals, Inc. UEI LM1CSJF7LLS6
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $402,225
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Place of performance
- Worcester, MA 01605, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $402,225 |
Quick answers
Who received award R43GM130187?
R43GM130187 was awarded to Zata Pharmaceuticals, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on September 1, 2018.
How much is award R43GM130187 worth?
$402,225 has been obligated on R43GM130187.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award